Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$254,828,520
+$51,132,577 QoQ
Shares Held
212,458
-4.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#234
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. LLY ranks #1 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
212,458 | $254,828,520 | |
| 2 | JNJ |
Johnson & Johnson
|
550,760 | $139,876,517 | |
| 3 | ABBV |
AbbVie Inc.
|
409,814 | $103,125,594 | |
| 4 | MRK |
Merck & Co., Inc.
|
565,110 | $72,616,635 | |
| 5 | AMGN |
Amgen Inc
|
138,472 | $50,143,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
284,053 | $35,887,256 | |
| 7 | PFE |
Pfizer Inc
|
1,303,824 | $31,396,081 | |
| 8 | AZN |
Astrazeneca PLC
|
149,538 | $28,355,395 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,828,520 | 212,458 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $203,695,943 | 221,464 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $246,230,704 | 229,120 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $179,533,900 | 235,300 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $184,863,980 | 237,148 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $198,010,270 | 239,748 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $188,429,760 | 244,080 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $214,220,292 | 241,800 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $229,377,117 | 253,349 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $173,231,465 | 222,674 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $133,731,174 | 229,416 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $125,410,186 | 233,482 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $110,872,968 | 236,413 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $79,688,207 | 232,043 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $85,756,920 | 234,411 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $77,260,278 | 238,937 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $78,369,957 | 241,711 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $70,762,599 | 247,102 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $48,455,064 | 175,422 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $41,433,041 | 179,325 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $42,357,227 | 184,547 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $35,414,533 | 189,565 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $32,555,391 | 192,818 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $29,793,613 | 201,281 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $36,163,107 | 220,265 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $30,211,551 | 217,788 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||